
Keywords: اسموپرازول; aspirin; creatine; esomeprazole; fetal growth restriction; intrauterine growth restriction; low-molecular-weight heparin; melatonin; N-acetylcysteine nitric oxide donor; pravastatin; preeclampsia; sildenafil; small for gestational age; vascular endothelia